South Africa Veterinary Medicine Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), By Animal, By Route of Administration, By Distribution Channel, And Segment Forecasts

South Africa Veterinary Medicine Market Summary

Similarly, increasing pet ownership and rising poultry disease outbreaks like bird flu/high pathogenicity avian influenza (HPAI) are also driving the market growth.

In recent years, the country has experienced rapid developments in the regulatory environment related to veterinary medicines. The authorities are attempting to ensure that the approval of new veterinary drugs is completed in a structured and thorough manner. These steps are being taken due to the increasing number of disease outbreaks among the veterinary population and a rise in illicit veterinary drug sales in the country.

South Africa is largely dependent on its poultry sector in terms of total animal production. According to data published by the South African Poultry Association (SAPA), in 2024, poultry meat contributed 36.4% of animal-product value (up from 35.2% in 2023) and 15.7% of total agricultural gross value (up from 14.9% in 2023). Out of the poultry population, over 74% are used for meat production, and 26% for egg production. Such dependence on the poultry sector increases demand for medicines, such as vaccines, anti-infectives, medicated feed additives, and parasiticides, among others, to ensure healthy meat or eggs are produced from these chickens.

The country recently faced bird flu outbreaks across various major poultry-producing areas. According to a November 2023 SAPA report, to avoid the spread of bird flu, over 8.5 million chickens (approximately 20-30% of the country's total poultry stock) were culled by the authorities. This included over 2.5 million broiler breeder chickens and 6 million layer chickens, creating a supply shortage in the country. However, the authorities quickly took the necessary steps, such as ensuring ample availability of veterinary medicines and timely import of poultry products, to circumvent the supply shortage.

Such situations drive the demand for veterinary drugs like vaccines, antibiotics, and medicated feed additives, among others, by increasing the emphasis on preventive measures, boosting treatment rates for recovering the poultry stock, ensuring quality control of imported products, etc. In November 2025, South Africa’s Minister of Agriculture announced a nationwide vaccination program for the entire national cattle herd against Foot-and-Mouth Disease (FMD) in 2026.

Furthermore, another driving factor for this market in South Africa is the growing support initiatives from around the globe to improve animal health in the country. As recently as April 2024, the World Veterinary Association (WVA), in collaboration with the South African Veterinary Association (SAVA), conducted the 39th Annual WVA Congress in South Africa. This initiative was aimed at boosting the market in the country by enhancing global exposure, enabling knowledge exchange among the industry participants, and creating networking opportunities, as well as attracting veterinary practitioners, researchers, veterinary medicine manufacturers, and other industry professionals from across the globe to encourage collaborative steps to advance veterinary care in the country, thus driving demand for advanced veterinary medicines.

Furthermore, as per a December 2023 article published by the South African Veterinary Council (SAVC), veterinarians and veterinary nurses were reinstated among the country's critical skills list. This step was taken to address the country's major shortage of veterinary professionals by streamlining the process for foreign professionals to work in the country. This strategy drives the market by attracting additional veterinarians to South Africa, potentially leading to the establishment of new veterinary facilities. This will naturally increase demand for veterinary medicines as the penetration of veterinary care reaches an even larger population, boosting the market. The country currently has 60-70 veterinary professionals per million people, which is significantly lower than the standardized international standard.

Market Concentration & Characteristics

Global industry players offering veterinary medicine are attempting to expand into the South African market through local distributors. They are introducing their product range by assessing the country's demand. Some global companies are trying to capture the South Africa veterinary medicine market share by acquiring domestic distributors.

The market is populated by a wide array of product substitutes. Apart from leading global players, many domestic players compete by offering cheaper and generic alternatives to customers. This market is also facing a looming threat of illicit veterinary drugs that can harm the health of animals and the adoption of legitimate veterinary drugs.

The market is witnessing M&A Activities, where the global leaders are attempting to increase their influence on the country market by acquiring their distribution partners. This strategy enables companies to leverage the distributor's established network and provide them with a direct presence in the market, rather than an indirect one.

The degree of innovation is primarily evident in the research and development of biological therapies for animals. These therapies include vaccines, stem cell therapies, and personalized therapies, among others. Also, manufacturers are focusing on developing veterinary medicines that are more palatable to ensure proper animal compliance.

South Africa is known to have very stringent rules and processes due to the presence of a dual registration system for the approval of veterinary medicines. Data protection and integrity are areas for improvement for the regulatory authorities in the country. The approvals of veterinary medicines are known to cause long delays, and a lack of financial resource availability is a major barrier to the market. These factors are expected to inhibit market growth by limiting the scope for product innovation.

Product Insights

The pharmaceuticals segment held the largest market share of 59.0% in 2024. The growth can be attributed to the vast array of products available in this segment and their application across several animal ailments. For example, parasiticides are the most commonly used pharmaceuticals due to the frequent infestation of parasites such as fleas and ticks. Furthermore, drugs such as anti-infectives, anti-inflammatory agents, and analgesics are the primary line of animal treatment before shifting to more advanced treatments like vaccines and stem cells.

The biologics segment is expected to grow at the fastest CAGR over the forecast period. The growth outlook is due to the growing number of pet and livestock ownership in South Africa, rising diseases and outbreaks in both livestock and poultry, along with increasing government support for vaccination, and advancements in biologics and vaccine technology. These factors altogether lead to the rising demand for new-generation, more effective, and safer biologics in the country.

The medicated feed additives segment is expected to grow at a robust CAGR over the forecast period. This growth is attributed to their palatability and ease of animal compliance, which increases their adoption among a variety of animals. These factors ensure that animals consume the feed additives without any barrier and reduce the requirement of additional measures to deliver necessary medication & nutrition. In South Africa, animal production is largely dependent on poultry, followed by livestock, swine, and other species. Considering the large populations of these livestock, medicine delivery through feed is the most efficient way to ensure swift intake of a variety of essential nutrients.

Animal Insights

The production animal segment held the largest market share of over 64.4% in 2024 and is expected to grow at the fastest CAGR over the forecast period. This can be attributed to an increasing number of regional disease outbreaks. In January 2024, a report published by the South African Department of Agriculture, Land Reform, and Rural Development stated that the country had experienced over 215 Foot-and-Mouth Disease (FMD) outbreaks since 2022. Furthermore, according to an April 2024 publication by the Food & Agriculture Organization (FAO), there have been approximately 87 outbreaks of highly pathogenic avian influenza (HPAI) in South Africa since October 2023, affecting species such as poultry and ostrich, among others. Such outbreaks increase the demand for veterinary medicines to aid in the treatment and management of these diseases, driving the market to lucrative growth.

The companion animal segment is expected to expand notably over the forecast period, driven by the country's growing popularity of pet adoption. According to a 2024 article published by Dogster, 45% of South African adults own some or other type of pet, and around USD 2,000 is spent annually on pet care in the country. This highlights the expanding demand for pet medicines in the country, driving the market with significant growth.

Route of Administration Insights

The injectable segment held the largest market share, approximately 45.0%, in 2024. Some of these benefits include a rapid onset of action, circumvention of first-pass metabolism, higher drug bioavailability, accurate control over the drug dosage, and reduced drug interactions, among others. In addition, other delivery modes, such as oral & topical, face a compliance issue from the animals, i.e., they may not easily ingest the required dosage, which may lead to wastage of the drug. But in the injectable mode of delivery, the drug or medicine is directly administered into the system of the animal via injection, eliminating the compliance barrier and ensuring rapid delivery of the medicine to its intended location.

The topical segment is projected to experience the fastest CAGR over the forecast period. This growth is primarily driven by factors such as ease of use, convenience for owners, the need to control ticks and fleas across pets and livestock, and product innovation. The livestock and companion animals in South Africa face significant tick/flea issues, which increases the demand for fast, topical treatments for vectors that transmit disease. For cattle and sheep, pour-ons and topical spray applications are more rapid, safer, and easier to apply across many animals as compared to injections. This practical advantage drives the demand for convenient and effective topical veterinary medicines in the forecast period.

Distribution Channel Insights

The veterinary hospitals & clinics segment held the largest market share of around 40.0% in 2024. This can be attributed to these facilities offering on-site pharmacies, ensuring all the required medications are available. Since products like vaccines & pharmaceuticals are generally prescription-only medications in veterinary medicine, these channels are the first preference of the animal owners for procuring the required medications. Apart from the on-site pharmacies, these settings also conduct health camps to ensure the penetration of animal care, thereby ensuring a lucrative procurement of medications in hospitals & clinics to avoid shortages. Many industry participants often conduct such camps by collaborating with these hospitals and clinics.

The e-commerce segment is expected to grow at the fastest CAGR over the forecast period. This distribution channel offers convenience and accessibility to animal owners. The pet or the livestock owner can easily order the medications from the comfort of their home or farm. Online stores and e-commerce platforms offer a variety of products at competitive prices, giving customers the choice to choose the product as per their requirements. E-commerce also helps veterinary facilities procure medications according to their requirements and convenience, without requiring direct contact with the sales executives of the manufacturers. 

Key South Africa Veterinary Medicine Company Insights

Market players are using multiple strategies to improve their market presence. Global leaders are engaging in initiatives to ensure the penetration of various veterinary medicines into the South African market. Major players are launching various initiatives, including vaccination programs, training programs for veterinarians, and donation activities, to combat the most prevalent animal diseases. These programs generally cover multiple countries from the Sub-Saharan region of Africa, like Nigeria, Uganda, and South Africa, among others.

Zoetis is a global leader in animal health with a strong presence in South Africa. The company manufactures animal medicines such as vaccines, antibiotics, parasiticides, and diagnostic tools for livestock and pet animals. In addition, the company offers services such as herd health management and veterinary support programs that help farmers and veterinarians in South Africa to prevent diseases and improve animal productivity.

Recent Developments

• In July 2025, Vaxxinova acquired Deltamune (Pty) Ltd, a major animal health firm in South Africa, from Phatisa. As a leading livestock vaccines manufacturer, Deltamune's integration provides Vaxxinova with a strong research, development, and production base to expand its vaccine and animal health products throughout Sub-Saharan Africa.

• In October 2024, Phibro Animal Health Corporation completed the acquisition of the Medicated Feed Additive (MFA) product portfolio and certain water-soluble products of Zoetis.

• In March 2023, Zoetis received an investment of USD 15.3 million from the Bill & Melinda Gates Foundation for developing innovative solutions for improving health and productivity in livestock from Sub-Saharan Africa. This investment will expand the company’s African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative to improve animal health by ensuring an ample supply of veterinary pharmaceuticals and biologics, among others.

South Africa Veterinary Medicine Market Report Scope

South Africa Veterinary Medicine Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the South Africa veterinary medicine market report based on product, animal, route of administration, and distribution channel:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Biologics

    • Vaccines

      • Modified/ Attenuated Live

      • Inactivated (Killed)

      • Other Vaccines

    • Other Biologics

  • Pharmaceuticals

    • Parasiticides

    • Anti-infectives

    • Anti-inflammatory

    • Analgesics

    • Others

  • Medicated Feed Additives

• Animal Outlook (Revenue, USD Million, 2021 - 2033)

  • Production Animals

    • Poultry

    • Pigs

    • Cattle

    • Sheep & Goats

    • Others

  • Companion Animals

    • Dogs

    • Cats

    • Horses

    • Others

• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

  • Oral

  • Injectable

  • Topical

  • Other Routes

• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Veterinary Hospitals & Clinics

  • E-commerce

  • Offline Retail Stores

  • Others